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Physiological interactions between the nervous and immune systems with components of the local microen-
vironment are needed to maintain homeostasis throughout the body. Dynamic regulation of bone remodel-
ing, hematopoietic stem cells, and their evolving niches via neurotransmitter signaling are part of the host
defense and repair mechanisms. This crosstalk links activated leukocytes, neuronal, and stromal cells, which
combine to directly and indirectly regulate hematopoietic stem cells. Together, interactions between diverse
systems create a regulatory ‘‘brain-bone-blood triad,’’ contributing an additional dimension to the concept of
the hematopoietic stem cell niche.Many specialty-tailored studies traditionally focus on a certain
body system of interest: its components, structure, activity,
and regulators. Advanced technology and modern data analysis
tools have begun to support a proliferation of interdisciplinary
studies. This type of research often unravels reciprocal impacts
and regulatory crosstalk between different systems that com-
bine to control the function of a complex tissue, organ, or even
the individual as a whole.
During recent decades, extensive research in the fields of
the immune and hematopoietic systems has characterized the
nature of hematopoietic stem cells (HSC), their phenotype, loca-
tions, regulators, and functional potential. A complex net of
dynamic interactions has been revealed, indicating that this
unique hybrid system is regulated in a cooperative and recipro-
cal manner with other systems in the body. It should be noted
that HSC populations are largely heterogeneous and often con-
tain subsets of more mature progenitors. Thus, in many cases
within the published literature, combined stem and progenitor
cells (HSPC) have been examined rather than more purified pop-
ulations of HSC. Studies that have examined HSC demonstrate
that stem cells must be considered in the context of their micro-
environment. Recent publications describe reciprocal regulatory
effects between players, both cellular and extracellular, across
systems that had once been believed to be distinct.
The following examples may better demonstrate this progres-
sion in conventional thinking and illustrate the intersystem regu-
lation of HSPC. In the seventies, the existence of stem cell niches
that regulate HSPC was suggested (Schofield, 1978). The bone
marrow (BM) stromal microenvironment was reported to exert
selective inhibitory regulation on adherent progenitors, prevent-
ing their differentiation while promoting their proliferation poten-
tial (Zipori and Sasson, 1980). These and other studies paved the
way for more recent findings, discussed later in this review, that
better characterize HSPC niches and their regulatory functions.
Based on such studies, in this review we consider HSPC
regulation and blood cell production as part of a dynamically
orchestrated regulatory crosstalk designed to maintain homeo-484 Cell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc.stasis and to provide rapid responses in conditions of stress.
The nervous system, located at the top of the proposed regula-
tory hierarchy, exerts direct and indirect effects on stem cells,
the immune system, the bone, the BM vasculature, and the
supportive stromal microenvironment. Existing data support
the presence of a ‘‘brain-bone-blood triad,’’ given that additional
signals elicited from the range of neural target populations feed
back on the other members of the regulatory pool. Within the
brain-bone-blood axis, some signals are delivered to the HSPC
pool directly, while other effects are exerted indirectly via an
impact on niche-supporting stromal cells.
Steady-State Niche Regulation of Stem Cell
Retention and Egress
Homeostasis is the process by which living organisms survive by
maintaining an immensely complex dynamic equilibrium within
their internal milieu. This condition of responsive stability is of
utmost importance in hematopoiesis, in which a rare population
of HSCs continuously maintains the blood circulation throughout
adult life by giving rise to enormous numbers of mature myeloid
and lymphoid cells and replenishing these pools due to the finite
life span of differentiated cells. In steady-state conditions, most
primitive HSPC are retained in the BM; however, very low levels
of quiescent progenitors are also found circulating in the periph-
eral blood and even in lymph fluids (Laird et al., 2008; Lapidot
et al., 2005; Wright et al., 2001). The physiological role of circu-
lating HSC, their turnover rate, destination, and fate are currently
unknown. These cells can repopulate damaged BM, continu-
ously repopulate the thymus, and participate in immune surveil-
lance as part of host defense and repair (Laird et al., 2008). In
parabiotic mice engineered to share combined circulatory
systems, cross-engraftment was observed at high levels in the
blood and spleen and at low levels in the BM, despite the phys-
iological barriers posed by the endothelium and extracellular
matrix (ECM). These results suggest that circulating progenitors
play a functional role during steady-state physiological condi-
tions (Abkowitz et al., 2003).
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that support and regulate the function of the primitive hemato-
poietic pool. These spatial locations have been identified in the
endosteum, at the interface between the bone and BM cavities,
as well as around sinusoids and their surrounding reticular cells.
The relationship between these niches and the HSPC popula-
tions found at each site is not yet clear. In addition to the BM,
extramedullary hematopoiesis can occur in the spleen and liver
and is increased under stress and various pathological condi-
tions (Adams and Scadden, 2006; Arai and Suda, 2007; Kiel and
Morrison, 2008; Sugiyama et al., 2006; Zhang and Li, 2008). The
interactions between the chemokine stromal-derived factor-1
(SDF-1, also named CXCL12) and its major receptor, CXCR4,
are essential to maintain HSPC within their niches. SDF-1 is pro-
duced at high levels by endosteal osteoblasts and endothelial
and reticular cells, whereas CXCR4 receptors are expressed
by immature and mature stromal and nerve cells, as well as
by most hematopoietic cells, including primitive populations.
SDF-1/CXCR4 interactions transmit signals for HSPC migration,
survival, anchorage, andquiescence (Dar et al., 2006;Nagasawa,
2006; Ponomaryov et al., 2000). Moreover, SDF-1 was found to
regulate both hematopoietic and stromal human stem cells, pro-
moting their survival and development (Kortesidis et al., 2005).
SDF-1-deficient murine embryos havemultiple lethal defects, in-
cluding impaired brain, heart, and abdominal blood vessel devel-
opment. Thesemicealso exhibit an impaired immunesystemand
suffer lack of BM seeding by immature progenitors in the devel-
oping embryo (Nagasawa, 2006). In addition, SDF-1 or CXCR4
neutralization in immune-deficient recipient mice prevented their
BM repopulation by transplanted humanCD34+HSPC (Dar et al.,
2006; Peled et al., 1999). Moreover, immature murine Sca-1+/
c-kit+/lineage negative cells (SKL), a subset of which are repopu-
lating HSCs, are attached to SDF-1-expressing stromal cells
(Tokoyoda et al., 2004). The more enriched, primitive SLAM cells
(Kiel andMorrison, 2008) are adjacent toSDF-1-expressing retic-
ular cells (CAR) (Sugiyama et al., 2006). Transplanted SKL cells
home to and are retained attached to SDF-1-expressing BM
endothelium (Sipkins et al., 2005), thus indicating SDF-1 involve-
ment in the retention ofHSPC in their BMendosteal, reticular, and
endothelial niches.
Several other molecules within hematopoietic niches, includ-
ing osteopontin and cytokines such as SCF and its receptor
c-kit, have been shown to regulate the quiescent state of long-
term repopulating HSCs (Adams and Scadden, 2006; Kiel and
Morrison, 2008). ECMmolecules such as hyaluronan also impact
murine (Haylock and Nilsson, 2006) and human (Avigdor et al.,
2004) HSPCmaintenance, propagation, homing, and homeosta-
sis via itsmajor receptor CD44. In addition, the ability of niches to
impact the function of resident HSPCs is also subject to dynamic
regulation, as evidenced by the role of various enzymes that
modulate the BM microenvironment. These factors include
neutrophil elastase (Levesque et al., 2001; Petit et al., 2002), hep-
aranase (Spiegel et al., 2008), and matrix-metalloproteinases
(MMPs), such as secreted (MMP-9) (Heissig et al., 2002). As
detailed in subsequent sections, a tight balance of the activity
of these enzymes is needed to maintain HSC in their niches.
Cell adhesion is another essential component of HSPC regula-
tion. More than 20 different adhesion receptors have been
identified on HSPC, including sialomucins, cadherins, immuno-globulins, integrins, and selectins (Chan andWatt, 2001; Prosper
and Verfaillie, 2001). Aside from retaining HSPC in the BM via
adhesion interactions, engagement of adhesion receptors on
hematopoietic progenitor cells by BM stromal ligands can also
transmit signals and play important roles in proliferation, survival,
and differentiation of HSPC (Simmons et al., 1997; Verfaillie et al.,
1994). Key signaling pathways, such as Notch, Hedgehog, and
Wnt, have been associated with both human and murine HSPC
function (Bhardwaj et al., 2001; Duncan et al., 2005; Murdoch
et al., 2003; Reya et al., 2003; Trowbridge et al., 2006). An addi-
tional pathway strongly affecting stem cell retention in their BM
niches involves calcium released from the bone by resorbing
osteoclasts. Calcium-sensing receptor (CaR)-deficient primitive
cells obtained from the fetal liver of CaR-knockout murine
embryos can successfully home to the BM of adult wild-type
recipients but cannot localize to the endosteum region (Adams
et al., 2006). Finally, deletion of the leukocyte specific phospha-
tase CD45 directly affects adhesion and motility of leukocytes in
general and of HSPC in particular. This deficiency is also mani-
fested in defective osteoclast function and impaired modulation
of endosteal niche components, which collectively reduce HSPC
levels present in the BM (Shivtiel et al., 2008). In all, the wide
variety of molecules involved in the regulation of HSPC homeo-
stasis suggests that these processes are highly complex and
tightly regulated.
Stress-Induced HSC Recruitment
Stress, at localized sites and at the level of the entire organism,
can be a powerful trigger for stem cell proliferation, differentia-
tion, andmobilization to the circulation, as well as for recruitment
to injured, infected, and inflamed tissues as part of host defense
and repair. Once stress conditions arise, the process of stem cell
recruitment is dramatically amplified. Several observations have
demonstrated that acute and chronic psychological stress can
induce progenitor mobilization (Grisaru et al., 2001). Inflamma-
tory signals exerted by LPS, which mimics systemic bacterial
infections, induce robust and rapid mobilization of immature
and maturing leukocytes from the BM reservoir. Mild bleeding
results in accelerated HSPC mobilization and peripheral blood
cell production aimed at replenishing the depleted cells. These
events are accompanied by increased osteoclast activity in the
BM endosteal region (Kollet et al., 2006). Organ injury is also
associated with HSPC mobilization via active participation of
chemokines, cytokines, and proteolytic enzymes expressed by
injured tissues. For example, SDF-1, HGF, and MMP-9 are
robustly produced in the injured liver, which consequently drives
HSPC to increase expression of CXCR4, enhances their migra-
tion to SDF-1, and amplifies recruitment into the circulation
(Kollet et al., 2003). IncreasedSDF-1 expression in injured organs
emerges as a common mechanism that recruits CXCR4+ HSPC
from the BM reservoir and targets them to the site of injury or
disease. This mechanism is described in various human patholo-
gies, including damaged skin (Ceradini et al., 2004), myocardial
infarction (Wojakowski and Tendera, 2005), autoimmune rheu-
matoid arthritis (Nanki et al., 2000), and ischemic brain (Hill
et al., 2004). Interestingly, physical exertions, such as engaging
in sport activities, can induce the egress of immature progenitors.
Early studies showed that exercise is accompanied by a rise in
progenitors in the blood (Barrett et al., 1978). A recent studyCell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc. 485
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increased the numbers of circulating immature CD34+ HSC and
elevated SDF-1 levels in the circulation (Zaldivar et al., 2007).
The existence of reverse regulation, demonstrating that primitive
hematopoietic progenitors exposed to stress can induce prefer-
ential osteoblastic differentiation, coupling HSPC action with
differentiation of bone progenitors has recently been suggested
(Jung et al., 2008).
For many years, various clinical observations suggested that
exposure of individuals to psychosocial stress can affect the
health status of an individual and disease outcomes in immune-
related disorders such as viral infections, chronic autoimmune
diseases, and tumors (Kemeny and Schedlowski, 2007). While
effects of psychosocial stress on mature leukocytes are well
documented (reviewed in Kin and Sanders, 2006), a similar role
on HSPC is not fully elucidated. Emerging evidence suggests
that neurological signals are involved in the communication
between the BM, the source of theHSPC, and the organ or tissue
that requires them. One example depicting the cooperation
between neuronal stress and stem cell mobilization can be found
in the reports dealing with lithium treatments. Lithium has been
used to treat mood cycling and bipolar disorders for many years.
Treatment with lithium is accompanied by neutrophilia (Murphy
et al., 1971) as well as by an elevation in granulocyte colony
formation in vitro (Tisman et al., 1973) and increased levels of
circulating human CD34+ HSC (Ballin et al., 1998). Two recent
studies have proposed a possible mechanism for these effects.
It has been shown that lithium induces downregulation of
CXCR4 expression on neutrophils and attenuates their response
toSDF-1 (Kimet al., 2007). In addition, lithium inhibits the function
of glycogen synthase kinase-3 (GSK-3) (Kast, 2008), thereby up-
regulating levels of b-catenin, which has been shown capable of
promoting HSPC proliferation (Reya et al., 2003). Furthermore,
GSK-3 inhibition also increases HIF-1 activity and results in en-
hanced SDF-1 and CXCR4-mediated migration and production
of immature human CD34+ cells (Kast, 2008). We found that
ex vivo direct stimulation of human CD34+ HPSCwith b-adrener-
gic agonists increase their proliferation and BM repopulating po-
tential via the canonical Wnt pathway and stabilization of b-cate-
nin (Spiegel et al., 2007). The Wnt antagonist Dickkopf-1 (Dkk)
mobilizes both hematopoietic and vasculogenic progenitor cells
via activation of osteoclasts in the stem cell-rich endosteum
region (Aicher et al., 2008). Interestingly, overexpression of Dkk
by endosteal osteoblasts leads to increased HSC proliferation,
revealing that Wnt activation in the niche is needed to limit HSC
proliferation and tomaintain their repopulation potential (Fleming
et al., 2008). Of note, Wnt effects are highly context dependent,
and varying effects of Wnt signaling on HSC have been reported
(reviewed in Staal et al., 2008).
In summary, systemic regulation of HSPC interactions with the
bone and BM microenvironment enables the body to overcome
stress situations and restore homeostasis.
Clinical HSPC Mobilization
Understanding the regulation of HSPC circulation has clinical im-
plications for their use in autologous and allogeneic transplants.
The low levels of circulating HSPC are drastically increased in
response to repeated stimulation with the cytokine G-CSF.
Mobilization mimics stress-induced recruitment of HSPC and is486 Cell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc.used clinically to harvest HSPC for transplantation protocols.
Indeed, the knowledge of how HSC mobilization is modified by
external stimuli comes primarily from clinical mobilization/collec-
tion paradigms. In addition to its effects on HSPC proliferation
andmobilization (Lapidot and Petit, 2002), G-CSF also increases
the homing and retention capacities of repopulating HSC,
namely by impacting their ability to actively cross the physical
blood/BM barrier, the endothelium, and thus relocate back to
the BM from the circulation (Abkowitz et al., 2003). Mobilizing
agents shown to induce massive egress of HSPC to the blood
include DNA-damaging agents (chemotherapy and irradiation),
cytokines, chemokines (Kollet et al., 2007; Lapidot and Petit,
2002), and the CXCR4 antagonist AMD3100 (Broxmeyer et al.,
2005), but not neutralizing CXCR4 or SDF-1 antibodies (Petit
et al., 2002). One of the main players in the mobilization process
is the SDF-1/CXCR4 axis. Dynamic levels of SDF-1 and CXCR4
expression induce proliferation of hematopoietic andmesenchy-
mal progenitors, recruitment of osteoblasts, bone-resorbing
osteoclasts, neutrophils, and other myeloid cells, leading to
leukocyte mobilization (Dar et al., 2006; Kollet et al., 2007; Korte-
sidis et al., 2005). Recently, we revealed that mouse osteoclasts
stimulated by the receptor activator of nuclear factor-kB ligand
(RANKL) are actively involved in homeostatic release, as well
as in accelerated, stress-induced recruitment and G-CSF mobi-
lization of HSPC to the circulation. This mobilization depends
on CXCR4, MMP-9, and cathepsin K activities. In parallel, ex-
pression of key factors in the endosteal HSPC niches, such as
SDF-1, SCF, and osteopontin, are reduced in response to
RANKL-induced osteoclast activity, suggesting that niche alter-
ations are linked with HSPC mobilization (Kollet et al., 2006). In
recent years, human HSPC mobilization has become the pre-
ferred source of repopulating HSPC for clinical transplantation
protocols, due to the higher cell yield of immature cells, shorter
time frame to reach successful repopulation, and reduced tech-
nical intervention and pain advantages compared to harvesting
cells from BM or cord blood (Lapidot and Petit, 2002).
Regulation of HSPC by the Nervous System
Recent studies depict a major regulatory role for signals by the
nervous system on various aspects of HSPC biology. For exam-
ple, Katayama et al. have recently shown that G-CSF-induced
mobilization ofmurine progenitor cells requires peripheral adren-
ergic signals (Katayama et al., 2006). According to the proposed
model, G-CSF activation of peripheral noradrenergic neurons
inducesmobilization of HSPC through suppression of endosteal,
bone lining osteoblasts, and a decrease in BM SDF-1 levels.
Additionally, a b2-adrenergic receptor (AdR) agonist rescues
the mobilization defects in mice deficient in dopamine b-hydrox-
ylase and augments G-CSF-induced mobilization (Katayama
et al., 2006; Mendez-Ferrer and Frenette, 2007). However, ques-
tions regarding the specific cell mediators of the observed
effects of G-CSF remain unsolved. Expression of AdR was
detected in enriched populations of mouse myeloid progenitors,
CD117+ and CD34+ multipotential cells, and even within pluripo-
tent stem cells, indicating that interrelations between neuronal
and hematopoietic progenitor signaling mechanisms are cer-
tainly possible (Muthu et al., 2007). This finding is in accordance
with previous results, indicating that b-AdR agonists affect DNA
synthesis in blood cell progenitors in vitro (Byron, 1972).
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nervous system (SNS) in hematopoiesis, demonstrating that
neurotransmitters regulate retention as well as proliferation and
recruitment of HSPC, not only indirectly through its effects on
bone-lining osteoblasts (Katayama et al., 2006) and bone-de-
grading osteoclasts (Kondo et al., 2005), but also through a direct
effect on HSPC (Spiegel et al., 2007). Our results further indicate
that immature human CD34+ progenitors dynamically express
neuronal receptors in a hierarchal orientation and in response
to stimulation with myeloid cytokines such as G-CSF. These
hierarchically arranged receptor expression patterns (higher in
themore primitive CD34+/CD38/low cells, enrichedwith repopu-
lating HSC, and lower levels in the committed CD34+/CD38+
progenitors, followed by high expression in certain lineages of
mature leukocytes andG-CSF-mobilized CD34+/CD38+ progen-
itors) imply a possible role for neurotransmitters in regulation of
HSPC migration, proliferation, and development.
Involvement of direct noradrenergic regulation was further
supported by the observation that norepinephrine and dopa-
mine serve as chemoattractants, and exposure to these neuro-
transmitters increased the migration potential of immature
human CD34+ cells (Spiegel et al., 2007). We also demonstrated
that treatment of enriched human progenitors with dopamine re-
ceptor (DR) agonists, epinephrine, or norepinephrine increased
expression and activity of MMPs, which are known to facilitate
progenitor motility. By modulating the chemotactic activity of
progenitors, neurotransmitters may play a role in controlling
the recirculation of this population between the BM, blood,
and other organs. Ex vivo treatment of enriched human
CD34+HSPC with the same DR agonists also led to increased
proliferation and colony formation in vitro as well as BM re-
population in transplanted, immune-deficient NOD/SCID mice
(Spiegel et al., 2007). These results broaden the role of the
SNS in hematopoiesis, implying that BM innervation regulates
the dynamic retention as well as proliferation and recruitment
of HSPC.
Bone Remodeling
In addition to thedirect influenceof catecholaminesonHSPC, the
crosstalk between the stem cell pool and its microenvironment
plays a pivotal regulatory role. In particular, the brain-bone axis
of the ‘‘brain-bone-blood triad’’ model has a major paracrine
impact on HSC via modulation of BM niches. As mentioned
earlier, SNS regulation of SDF-1 expression by endosteal bone-
lining osteoblasts is involved in HSPC mobilization (Katayama
et al., 2006). Thus, innervation of the HSPC niches, namely the
bone andBMmicroenvironment, has an important role in regulat-
ing hematopoiesis in general and HSPC in particular. To provide
an anatomical perspective of the landscape, BM nerve fibers run
along vessels within the hematopoietic parenchyma and be-
tween the layers of periarterial adventitial cells, concentrically
surround both nerves and arterioles (Mignini et al., 2003). The
close proximity of blood vessels and nerves in the BM suggest
additional cooperation between these systems for regulation of
the marrow space and bone surface environments. Various
factors have been characterized as overlapping regulators of
the immune, nervous, and vascular systems, such as VEGF,
SDF-1, and G-CSF. Importantly, when deregulated, the mutual
crosstalk between the vascular and nervous systems contributesto several diseases such as Parkinson’s disease and amyotro-
phic lateral sclerosis (Lambrechts and Carmeliet, 2006).
In mouse BM, norepinephrine originates mainly from sympa-
thetic nerve endings and is metabolized through specific enzy-
matic pathways, whereas epinephrine and dopamine may
originate from other sources such as the systemic circulation.
In addition, both sympathetic and sensory nerve fiber endings
have been found in the epiphyseal trabeculae growth plate, as
well as the metaphysis of mouse long bones (Mignini et al.,
2003). At these bone locations that correspond with HSC
niche-containing regions of the marrow, nerve endings were ob-
served in close contact with bone-lining osteoblasts and osteo-
clasts (Mignini et al., 2003). SDF-1 expression was also observed
in the murine bone growth plate following PTH treatment (Jung
et al., 2006), thus implying a direct nerve control of the BM
stem cell niches.
Bone remodeling is ahomeostatic process thatmaintainsbone
integrity and mass and is comprised of two main phases: depo-
sition by osteoblasts and resorption by osteoclasts. Several lines
of evidence indicate that this process is under profound control of
sympathetic innervation. Changes in bone mass were observed
in rats after sympathectomy (Cherruau et al., 1999) and in mice
deficient in genes coding for dopamine-hydroxylase (Kondo
et al., 2005) and a dopamine transporter (Bliziotes et al., 2000).
Mice lacking b2-AdR display increased bone mass, compared
with normal mice, indicating that the SNS helps to set the target
level of bone mass under normal conditions (Elefteriou, 2005).
Importantly, the SNS is able to regulate bone mass systemically
via impact on bone formation by osteoblasts (Kondo et al.,
2005; Togari et al., 2005).Of interest, in the absenceof bone load-
ing that mimics low gravity, signals from the SNS induce bone
loss through reduced bone formation by osteoblasts and also
via increased bone resorption by osteoclasts (Kondo et al.,
2005), thus explaining a well-known phenomenon of bone loss
by astronauts (Vico et al., 2000). SNS-induced decrease in bone
formation is mediated through b2-AdR on osteoblasts (Kondo
et al., 2005; Togari et al., 2005), suggesting that b-blockers may
be effective against osteoporosis, associated with increased
sympathetic activity. In fact, the use of b-blockers has been
accompanied by a reduced risk of fractures in postmenopausal
women (Bonnet et al., 2007). A direct effect of these drugs on
HSC function has yet to be reported but would be predicted
based on mouse studies of modified HSC number and function
in response to bone/osteoblast manipulations.
Recently, neural control of bone mass was further elucidated
by studying leptin, a hormone that is produced in fat cells and
affects food intake, body weight, and the neuroendocrine
system. After binding to its receptor on hypothalamic neurons,
leptin signaling increases expression of RANKL by osteoblasts,
resulting in a boost in the differentiation and resorbing activity
of osteoclasts. This change in osteoblast:osteoclast ratio leads
to a net enhanced degradation of bone (Takeda et al., 2002).
The increased expression of RANKL by osteoblasts is mediated
by signaling through the b2-AdR, but its effect is also corrected
by the leptin-induced expression of a hypothalamic neuropep-
tide cocaine- and amphetamine-regulated transcript (CART),
which inhibits the expression of RANKL in osteoblasts (Elefteriou
et al., 2005). Thus, leptin-dependent impact of bone mass is also
subject to a certain degree of homeostatic control.Cell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc. 487
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hormone estrogen. Its deficiency is one of the most frequent
causes of osteoporosis in aging women and a possible cause
of bone loss and insufficient skeletal development in men
(MacLean et al., 2008). The mechanism by which estrogen defi-
ciency causesbone loss remains largely unknown.At aminimum,
estrogen levels are known to impact immune functions including
TNF-a secretion by activated T cells, which affect osteoclast dif-
ferentiation and activity. Interestingly, ovariectomy in rats causes
a dramatic loss of bone-penetrating nerves (Burt-Pichat et al.,
2005). These observations suggest that estrogen may be pivotal
to the ability of the SNS to regulate bone formation. Discovery of
the RANKL/RANK/Osteoprotegerin (OPG) system, which is in-
volved in various forms of pathogenesis leading to bone loss
(Boyce and Xing, 2008), helped to understand how bone remod-
eling is regulated by the nervous, immune, and endocrine (via
estrogen) systems. This knowledge served as a basis for suc-
cessful application of b-blockers and RANKL inhibitors in the
prophylaxis and treatment of osteoporosis (discussed above;
Bonnet et al., 2007). Given that HSC, progenitor cells, and their
niches are in close proximity to the bone, SNS-derived impact
on bone remodeling affects the stem cells in a direct, as well as
an indirect, manner.
Circadian Rhythms Regulate Hematopoiesis
The data presented thus far have linked all three players of the
proposed ‘‘brain-bone-blood triad,’’ and yet the question of
what specific mechanisms drive nervous system regulation of
HSPC remains. Human and animal activities, physiological
processes, and behavior are subject to alterations mediated by
circadian rhythms. Circadian oscillations in steady-state hema-
topoiesis are well established, and daily variations in the prolifer-
ation of human BM cells, with a peak occurring at night, have
been known for more than four decades (Mauer, 1965). The cen-
tral pacemaker for circadian and seasonal variations in the body
is situated in the brain suprachiasmatic nucleus, which is part of
the sympathetic outflow from the brain to different organs and
tissues in the body (Bartness et al., 2001). Accordingly, substan-
tial amounts of catecholamines that are found in murine BM
exhibit daily fluctuations, with peak values observed during the
night, in parallel with the proportion of cycling cells (Cosentino
et al., 1998). Peripheral blood neutrophil and platelet counts
showed dramatic oscillations within a period of 14–23 and
21–35 days, respectively (Morley and Stohlman, 1970). Of inter-
est, the function of the immune system has been reported to be
not only under circadian and seasonal rhythms, but based on
anecdotal results, is also influenced by lunar cycles (discussed
in Zimecki, 2006).
G-CSF-induced leukocytosis was dependent on the timing of
G-CSF injections in mice (Ohdo et al., 1998), as well as in cancer
patients (Sato et al., 2002). Significant 24 hr fluctuations have
been observed in mouse BM granulocyte/macrophage colony-
forming units (CFU-GM), human BM quiescent and cycling
immature CD34+ cells, in their proliferative response to growth
factors (Tsinkalovsky et al., 2007), and engraftment of immune
deficient mice (D’Hondt et al., 2004).
Expression of key clock genes has been detected in immature
human BM CD34+ cells and in primitive murine SKL cells, and
expression patterns were coordinated with robust circadian488 Cell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc.oscillations (Mendez-Ferrer et al., 2008; Tsinkalovsky et al.,
2007). Importantly, these clock gene oscillations were accompa-
nied by antiphase fluctuations in SDF-1 protein andmRNA levels
in the BM, which appeared under profound control by the SNS.
In vitro experiments with murine stromal cells revealed that
SDF-1 production is regulated by locally delivered adrenergic
signals, mediated in the BM through b3-AdR, but not b2-AdR
or clock genes, suggesting involvement of additional stromal
elements in the physiological release of HSPC (Mendez-Ferrer
et al., 2008). In addition, circadian oscillations of CXCR4 on
BM HSPC have also been reported (Lucas et al., 2008).
Taken together, these observations clearly show that circa-
dian rhythms in steady-state and stress-induced conditions,
both in physiological and pathological settings, exert substantial
impact on hematopoietic, nervous, and immune systems and
their means of intercommunication. However, the mechanisms
and significance of these important and intriguing events remain
to be elucidated. In particular, the physiological meaning of
circadian variations in circulation of HSPC is still unclear. None-
theless, while attempts aremade to understand the direct effects
of the brain-bone-blood axis on HSC, the indirect impact of this
axis via the BM niches themselves must not be overlooked. The
observed increase in HSPC present in the blood may occur in
synchrony with circadian-determined bone-remodeling events.
Physiologically, such oscillations in HSPC location might
contribute to synchronized generation of vacant niches, as well
as their rapid reoccupancy by the most potent stem cells
selected by SNS-regulated cycles of migration and engraftment
(Scadden, 2008).
Perspectives
The environmental mechanisms that regulate stem cell function
are steadily being elucidated. A better understanding of these
mechanisms may lead to development of new strategies aimed
at improving therapeutic protocols. For instance, understanding
the impact of circadian rhythms on HSPC migration may inform
clinicians as to the optimal time of day to collect HSPC for
transplantation (Lucas et al., 2008).
In this review, we discussed recent data that introduce the
nervous system as an important regulator of HSPC, both directly
and indirectly via bone remodeling. The question of what regu-
lates the pool of HSPC, disseminated throughout many skeletal
bone cavities such that they function as the basis of a single
organ system, has remained an open question (Fliedner, 1998).
The data linking the nervous and hematopoietic systems offer
strong support for at least a partial answer. The nervous system,
which is the major regulatory organ of the human body, may
modify leukocyte homeostasis by influencing the migration and
localization of HSPC among different bones. Furthermore, regu-
lation of HSPC niches by the nervous system expands the
conceptual borders of the stem cell microenvironment and
adds another dimension to the term. In addition to homo- and
heterotypic cell-cell interactions (such as between HSPCs, oste-
oblasts, osteoclasts, endothelial cells, and reticular cells) that
require direct contact and chemokines, cytokines, proteolytic
enzymes, and growth factors that act in a paracrine manner
and are confined to act within proximal physical spaces, an
additional systemic level of regulation is provided by direct and
indirect effects of the nervous system (Figure 1).
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ReviewFigure 1. Schematic Model of Steady-State and Stress-Induced Interactions between the Nervous and Immune Systems with the Bone
Marrow Microenvironment
Hematopoietic stem and progenitor cells (HSPC), osteoclasts, as well as bone marrow (BM) stromal osteoblasts and endothelial cells express catecholaminergic
receptors and are able to respond to neuronal signals as part of homeostasis (left panel). In these conditions, HSPC are mainly attached to osteoblasts, endo-
thelial, and reticular (CAR) cells. They egress from the BM and transiently enter the bloodstream at very low levels. During the day, levels of HSPC in the blood
oscillate in an opposite manner to SDF-1 concentrations in the highly innervated BM microenvironment.
Stress, both physiological and induced, including exercise, clinical G-CSF stimulations, bleeding, organ injury, inflammation, etc., (right panel) is accompanied by
enhanced release of catecholamines and upregulation of b-AdR expression on HSPC. These are associated with a reduction in SDF-1 levels in the BM and
increase in the peripheral blood, as well as increased CXCR4 expression in the BM. In addition, these stress conditions trigger expansion and activation of
osteoclasts, and the release of various proteolytic enzymes enabling the robust mobilization of HSPC from the BM to the bloodstream to participate in host
defense and organ repair.Furthermore, given that mature immune cells are the progeny
of the HSPC themselves, the brain-bone-blood model also
encompasses an additional level of interaction and potential
feedback that may be considered. The nervous and immune sys-
tems, or the ‘‘super systems,’’ which are the ultimate regulators
throughout the body (Tada, 1997), are the two major adaptive
systems in homeostasis and alarm situations. Common traits
shared by these two systems include the establishment of
memory, the ability to distinguish between self and foreign, the
presence of dynamic responses to rapidly accommodate one’s
needs as part of a defense and repair strategy, and also a wide
distribution and influence throughout the body.
The presence of endocrine and paracrine activation of leuko-
cytes by neurotransmitters, secreted by the adrenal medulla
and nerve endings, respectively, has long been known. On top
of these classical pathways, emerging evidence suggests the
existence of an additional pathway for neurotransmitter activa-
tion of hematopoietic cells—autocrine activation. Endogenous
catecholamines were detected in different leukocytes, thus im-
plying the potential for catecholamine regulation of their function
via an autocrine loop. Moreover, different leukocyte populations
were shown to express enzymes involved in the synthesis of cat-
echolamines. Low levels of tyrosine hydroxylase (TH), as well as
dopamine, were detected in lymphocytes after incubation with
the dopamine precursor, L-dopa (Bergquist et al., 1994). Human
T regulatory cells selectively express TH and contain endoge-
nous dopamine, norepinephrine, and epinephrine (Cosentinoet al., 2007). The presence of an active dopamine uptake system
in lymphocytes has also been shown, suggesting that endoge-
nous catecholamines synthesized by various types of immune
cells play an important modulating role in their function, in addi-
tion to the impact of exogenous catecholamines (Idova et al.,
2004). Furthermore, it was recently demonstrated that activated
phagocytes are capable of de novo production of catechol-
amines, suggesting anautocrine/paracrine self-regulatorymech-
anismbycatecholaminesduring inflammation. Exposureof these
phagocytes to LPS induced the secretion of norepinephrine and
epinephrine and the expression of catecholamine-generating
enzymes, demonstrating the presence of complete intracellular
machinery for the generation, release, and activation by cate-
cholamines (Flierl et al., 2007). In such dual regulation of immune
function by catecholamines, the modulation by endogenous,
leukocyte-derived catecholamines may be more effective, as
lymphocytes can directly and rapidly induce an immune
response.
These results imply that leukocytes may ‘‘fine-tune’’ the
response to neurotransmitters via their intracellular reservoirs of
catecholamines. More importantly, these observations suggest
that leukocytes are not just respondents to regulation by the
nervous system but they may also actively influence it through
release of neurotransmitters. Thus, the hierarchy between the
systems should not be looked upon as a unidirectional communi-
cation in which the nervous system regulates host immunity, but
rather as bi- or even tridirectional when catecholamine effects onCell Stem Cell 3, November 6, 2008 ª2008 Elsevier Inc. 489
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Reviewstromal and bone elements are taken into consideration. Further
investigation is required in order to determine whether a similar
phenomenon occurs specifically within hematopoietic stem
cells. Do they have the ability to affect the nervous system and
modulate its action? The data reviewed above indicate that
activated leukocytes, the progeny of HSCs, are capable of syn-
thesizing and releasing neurotransmitters, and open the door
to the concept that the immune system can be regarded as
a ‘‘long arm’’ extension of the nervous system or as a diffusely
expressed adrenergic organ.
Furthermore, the concept of a multidirectional regulatory
network also emerges from evidence regarding the role of che-
mokines, cytokines, and hematopoietic cells in the regulation
of the central nervous system (CNS). These examples include
the observation that activated immune cells pass through the
blood brain barrier to release cytokines and chemokines directly
into the CNS (Quan and Banks, 2007) and that chemokines such
as SDF-1 and its major receptor CXCR4, cytokines such as
G-CSF, and even immune-derived microglia cells are all present
in the CNS. Interestingly, patients with early-stage Alzheimer’s
disease exhibit depleted SDF-1 in the blood (Laske et al.,
2008), as well as decreased levels of circulating, immature
CD34+ cells (Maler et al., 2006), suggesting a potential involve-
ment of hematopoietic progenitor cells in brain homeostasis.
Collectively, these data indicate that mutual regulation exists
between the nervous and the hematopoietic systems.
Though a bit speculative, one may argue that the reciprocal
regulation patterns highlighted throughout this review indicate
that the boundaries between these two major systems may be
less defined than believed previously. That is, in addition to the
nervous system influencing the development and homeostatic
regulation of blood cell-producing stem cells, the mature prog-
eny that comprise the immune system also appear to play their
part. In other words, rather than thinking in the terms of a
‘‘blood-brain barrier,’’ a more cooperative, partially overlapping,
side-by-side relationship may be more appropriate to describe
the crosstalk between the immune and nervous systems. The
result of this crosstalk, through direct means and also via inter-
actions with microenvironments throughout the body, is to main-
tain homeostasis and to prevent illness. Fundamental scientific
and medical questions regarding these issues remain to be
deciphered, and future investigations will be required in order
to address these concepts.
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